The Australian Government Will Give $33 Million to Researchers Studying Rare Cancers and Diseases

The Australian government will give $33 million to researchers to study rare cancers and rare diseases. The original article can be read here, at the Department of Health’s website. Background…

Continue Reading The Australian Government Will Give $33 Million to Researchers Studying Rare Cancers and Diseases
Results From Trials of Jakavi For Treating Polycythemia Vera and Myelofibrosis Have Been Released
stevepb / Pixabay

Results From Trials of Jakavi For Treating Polycythemia Vera and Myelofibrosis Have Been Released

The drug Jakavi (ruxolitinib) is being investigated as a possible treatment for polycythemia vera (PV) and myelofibrosis. Results from studies into this were presented by Novartis at the 23rd Congress of…

Continue Reading Results From Trials of Jakavi For Treating Polycythemia Vera and Myelofibrosis Have Been Released
The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma
Source: Pixabay

The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma

The U.S. Food and Drug Administration (FDA) has approved the medicine Keytruda for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma, that have relapsed…

Continue Reading The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma
The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma
Source: Pixabay

The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma

Pfizer has announced that the medicine Xalkori (crizotinib) has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for two potential treatment uses. The full article can be…

Continue Reading The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma
$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients
Source: Pixabay

$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients

The Melanoma Research Alliance (MRA) and The American Cancer Society (ACS) have announced the first recipients of their new research grants, reports PRNewswire. The grants have been set up as…

Continue Reading $2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients
A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia
Source: Pixabay

A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia

A phase 3 Murano clinical trial has shown that combining the drugs Venclexta (venetoclax) and Rituxan (rituximab) could be an effective treatment for chronic lymphocytic leukaemia, reports Cancer Updates, Research,…

Continue Reading A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia